Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2024-08-16 00:00:00 ET · period of report 2024-08-14 · accession 0001415889-24-021452 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-16 | 2024-08-14 | ANAB | Lizzul Paul F. | Chief Medical Off | S - Sale+OE | $40.00 | -2,000 | 11.6K | -15% | -$80.0K |
| D | 2024-08-16 | 2024-08-14 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | $18.50 | +2,000 | 13.6K | +17% | +$37.0K |
| D | 2024-08-16 | 2024-08-14 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | $0.00 | -2,000 | 86.5K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-14 | S | D | 2,000 | $40.00 | 11,618 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-14 | M | A | 2,000 | $18.50 | 13,618 | D | — | — | |
| 3 | Derivative | Common | 2024-08-14 | M | D | 2,000 | $0.00 | 86,500 | D | $18.50 · — to 2030-07-29 | 2,000 Common | (F3) In addition to the remaining options to purchase 86,500 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 297,610 shares of common stock, which options vest according to their terms. (F2) The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 31, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |